Navigation Links
Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
Date:12/20/2007

- Study Identifies Novel Biomarkers Displaying 90% Sensitivity in Breast

Cancer -

ST. LOUIS, Dec. 20 /PRNewswire/ -- Orion Genomics announced today the discovery and validation of the most frequent DNA alterations detected in breast cancer to date. The results of a genome-wide analysis of DNA methylation appeared in PLoS ONE. The study entitled, "Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer" found more than 50 novel biomarkers, which were subsequently validated in up to 230 independent patient samples.

"Our study identified novel biomarkers that were individually capable of distinguishing early stage ductal breast cancer from normal and benign breast tissue," commented Jared Ordway, Ph.D., Director of Research and Development at Orion Genomics. "We are very excited about the potential of these findings as these biomarkers may be critical in the development of molecular diagnostics for the early detection of breast cancer."

Researchers applied a patented microarray-based approach to map tumor associated changes in DNA methylation, alterations that can affect normal gene expression. A single locus associated with the GHSR gene was the most powerful biomarker in the study, with a clinical sensitivity of 90% and a specificity of 96% for infiltrating ductal breast carcinoma. In addition to identifying biomarkers that might aid in the detection of breast cancer, the research revealed insights into the molecular mechanism of tumor development, which may lead to advances in breast cancer treatment.

"Twelve of our more than fifty breast cancer biomarkers exceeded the highest sensitivity previously reported for the stratification of tumor and normal tissue," added Nathan D. Lakey, President and CEO of Orion Genomics. "These results validate our biomarker discovery platform and our product pipeline, which is focused on breast, lung and ovarian cancer diagnostics."

About Orion Genomics

Orion Genomics, the Second Code biotechnology company, develops genomic research tools and molecular diagnostic products to detect cancer at its earliest stages and to aid in appropriate therapy selection. The company has active biomarker discovery programs in cancers of the bladder, breast, lung, ovaries and colon. Orion Genomics is located in the Center for Emerging Technologies in St. Louis. For more information, visit http://www.oriongenomics.com.


'/>"/>
SOURCE Orion Genomics
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2018)... ... 2018 , ... NCPDP announced today that its NCPDP ... of the NCPDP SCRIPT Standard Version 2017071 ahead of the January 1, 2020, ... the industry as vital enhancements in improving patient safety, clinical decision-making, and business ...
(Date:9/12/2018)... ... 12, 2018 , ... Patient experience and population health leader ... Population Engage patient experience suite. Express Surveys are short, streamlined patient experience ... a wealth of strategic and tactical knowledge in order to take meaningful action. ...
(Date:9/12/2018)... ... , ... Donaldson Plastic Surgery has been included on the Inc. 5000 list ... list of central Ohio's fastest growing businesses. The plastic surgery practice was ranked number ... is the only medical practice and plastic surgery office to make the regional Fast ...
Breaking Medicine Technology:
(Date:9/7/2018)... ... 07, 2018 , ... Start your engines and race to the new ... to choose. Pedal power is the name of the game here – whether it’s ... on the miniature Indianapolis Motor Speedway oval. , The timing couldn’t be better with ...
(Date:9/2/2018)... TRUMBULL, Conn. (PRWEB) , ... ... ... Aesthetics & Mammography is proud to add HydraFacial MD® Elite to its ... treatment that uses patented, vortex-suction technology and an infusion of clinically-proven ingredients ...
(Date:9/1/2018)... ... ... Alice Branton shared her personal story on NBC Daytime about how her ... , With all the medical advancements over the last hundred years, vitamin D ... problem worldwide irrespective of age, location, ethnicity, and gender. Even in those residing in ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... neuroimaging capabilities with the addition of an MRI Simulator. In the MRI Simulator, ... including sounds. By engaging in this mock scan experience, research participants become accustomed ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... the impact of a biofield energy treated nutraceutical to improve overall immunity and ... immune function and blood, as well as, inflammation. The following data was reported:, ...
Breaking Medicine News(10 mins):